文献速递肝病

肝脏脂肪变程度与心脏及自主神经功能受损相关

The degree of hepatic steatosis associates with impaired cardiac and autonomic function.
PubMed 文献 · J Hepatol · 2019-02-13

研究纳入96名久坐个体,评估肝脏脂肪与心脏及自主神经功能的关系。非酒精性脂肪性肝病(NAFLD)和双病因脂肪性肝病(DAFLD)患者的心脏及自主神经功能较对照组显著受损,且肝脏脂肪变程度、代谢紊乱、炎症和纤维化分期与功能受损相关,酒精摄入影响较小。

要点

  • NAFLD和DAFLD患者的心脏及自主神经功能较对照组显著受损。
  • 肝脏脂肪变程度独立关联心脏功能,TNF-α和CK-18独立关联自主神经功能。
  • 纤维化分期与平均血压、舒张变异性和收缩变异性呈显著负相关。

核心结论

  • 心脏和自主神经功能受损似乎取决于肝脏脂肪水平、代谢功能障碍、炎症和纤维化分期,酒精摄入的影响较小。
  • 作者认为应寻求干预措施以调节NAFLD或DAFLD患者过高的心血管风险。

研究设计与样本

  • 研究评估了96名久坐个体的心血管和自主神经功能,分为三组:NAFLD组(n=46,磁共振波谱显示肝脏脂肪变>5%)、DAFLD组(n=16,肝脏脂肪变>5%且酒精摄入>20 g/天)和对照组(n=34,无心脏、肝脏或代谢疾病且酒精摄入<20 g/天)。

主要发现

  • NAFLD和DAFLD患者的心脏及自主神经功能较对照组显著受损。
  • 舒张变异性和收缩变异性(LF/HF-sBP [n/1])在NAFLD组为2.3(1.7)、DAFLD组为2.3(1.5),对照组为3.4(1.5),p<0.01;DAFLD个体较NAFLD患者舒张变异性降低。
  • 肝脏脂肪变和空腹血糖与每搏输出量指数呈负相关。
  • 纤维化分期与平均血压(r=-0.47,p=0.02)、舒张变异性(r=-0.58,p≤0.01)和收缩变异性(r=-0.42,p=0.04)呈显著负相关。
  • 肝脏脂肪变独立关联心脏功能(p≤0.01);TNF-α(p≤0.05)和CK-18(p≤0.05)独立关联自主神经功能。

临床怎么用

  • 作者认为应寻求干预措施以调节NAFLD或DAFLD患者过高的心血管风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Cardiovascular disease is the principle cause of death in patients with elevated liver fat unrelated to alcohol consumption, more so than liver-related morbidity and mortality. The aim of this study was to evaluate the relationship between liver fat and cardiac and autonomic function, as well as to assess how impairment in cardiac and autonomic function is influenced by metabolic risk factors. METHODS: Cardiovascular and autonomic function were assessed in 96 sedentary individuals: i) non-alcoholic fatty liver disease (NAFLD) (n = 46, hepatic steatosis >5% by magnetic resonance spectroscopy), ii) Hepatic steatosis and alcohol (dual aetiology fatty liver disease [DAFLD]) (n = 16, hepatic steatosis >5%, consuming >20 g/day of alcohol) and iii) CONTROL (n = 34, no cardiac, liver or metabolic disorders, <20 g/day of alcohol). RESULTS: Patients with NAFLD and DAFLD had significantly impaired cardiac and autonomic function when compared with controls. Diastolic variability and systolic variability (LF/HF-sBP [n/1]; 2.3 (1.7) and 2.3 (1.5) vs. 3.4 (1.5), p <0.01) were impaired in patients with NAFLD and DAFLD when compared to controls, with DAFLD individuals showing a decrease in diastolic variability relative to NAFLD patients. Hepatic steatosis and fasting glucose were negatively correlated with stroke volume index. Fibrosis stage was significantly negatively associated with mean blood pressure (r = -0.47, p = 0.02), diastolic variability (r = -0.58, p ≤0.01) and systolic variability (r = -0.42, p = 0.04). Hepatic steatosis was independently associated with cardiac function (p ≤0.01); TNF-α (p ≤0.05) and CK-18 (p ≤0.05) were independently associated with autonomic function. CONCLUSION: Cardiac and autonomic impairments appear to be dependent on level of liver fat, metabolic dysfunction, inflammation and fibrosis staging, and to a lesser extent alcohol intake. Interventions should be sought to moderate the excess cardiovascular risk in patients with NAFLD or DAFLD. LAY SUMMARY: Increased levels of fat in the liver impair the ability of the cardiovascular system to work properly. The amount of fat in the liver, metabolic control, inflammation and alcohol are all linked to the degree that the cardiovascular system is affected.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Houghton D, Zalewski P, Hallsworth K, et al. The degree of hepatic steatosis associates with impaired cardiac and autonomic function. J Hepatol. 2019. PMID: 30769007. doi:10.1016/j.jhep.2019.01.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。